|
BioVentures Investors LLC |
|
United States |
+1 (617) 252-3443 |
Series D |
|
|
|
Clarus Ventures LLC |
Life sciences venture capital firm |
United States |
+1 (617) 949-2200 |
Series D |
|
|
|
Dogwood Equity |
|
United States |
+1 (704) 362-1800 |
Series D |
|
|
|
Dow Venture Capital |
The corporate venture capital unit of Dow Chemical Co |
United States |
+1 (989) 636-5692 |
Series C |
|
|
|
Dow Venture Capital |
The corporate venture capital unit of Dow Chemical Co |
United States |
+1 (989) 636-5692 |
Series D |
|
|
|
Easton Capital Investment Group |
|
United States |
+1 (305) 285-0220 |
Series C |
|
|
|
Intersouth Partners |
Venture capital firm based in Durham, North Carolina. |
United States |
+1 (919) 493-6640 |
Series B |
|
|
|
Intersouth Partners |
Venture capital firm based in Durham, North Carolina. |
United States |
+1 (919) 493-6640 |
Series C |
|
|
|
Intersouth Partners |
Venture capital firm based in Durham, North Carolina. |
United States |
+1 (919) 493-6640 |
Series D |
|
|
|
Investor Growth Capital Inc (IGC) |
The wholly owned venture capital arm of Investor AB |
United States |
+1 (212) 515-9000 |
Series C |
|
|
|
Investor Growth Capital Inc (IGC) |
The wholly owned venture capital arm of Investor AB |
United States |
+1 (212) 515-9000 |
Series D |
|
|
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) |
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
United States |
+1 (732) 524-3218 |
Series C |
|
|
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) |
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
United States |
+1 (732) 524-3218 |
Series B |
|
|
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) |
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
United States |
+1 (732) 524-3218 |
Series D |
|
|
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) |
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
United States |
+1 (732) 524-3218 |
N/A |
|
|
|
JP Morgan & Co |
|
United States |
|
Series D |
|
|
|
JP Morgan & Co |
|
United States |
|
Series C |
|
|
|
Kitty Hawk Capital |
|
|
|
Series B |
|
|
|
Mitsui & Co Global Investment Inc (三井グループ) |
|
United States |
|
Series D |
|
|
|
Mitsui & Co Global Investment Inc (三井グループ) |
|
United States |
|
Series C |
|
|
|
Mitsui & Co Global Investment Inc (三井グループ) |
|
United States |
|
Series B |
|
|
|
OrbiMed Advisors LLC |
American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
United States |
+1 (212) 739-6400 |
Series D |
|
|
|
OrbiMed Advisors LLC |
American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
United States |
+1 (212) 739-6400 |
N/A |
|
|
|
Polaris Venture Partners Inc |
Multistage venture capital investors with focus Technology, Healthcare and Consumer |
United States |
+1 (781) 290-0770 |
Series B |
|
|
|
Polaris Venture Partners Inc |
Multistage venture capital investors with focus Technology, Healthcare and Consumer |
United States |
+1 (781) 290-0770 |
Series C |
|
|
|
Quaker BioVentures Inc |
|
United States |
+1 (215) 988-6800 |
Series D |
|
|
|
Quaker BioVentures Inc |
|
United States |
+1 (215) 988-6800 |
Series B |
|
|
|
Quaker BioVentures Inc |
|
United States |
+1 (215) 988-6800 |
Series C |
|
|
|
Reference Capital Management LLC |
|
United States |
+1 (503) 619-4310 |
N/A |
|
|
|
Tall Oaks Capital Partners LLC |
|
United States |
+1 (434) 951-0440 |
N/A |
|
|
|
Village Ventures Inc |
|
United States |
+1 (413) 458-1100 |
N/A |
|
|